ProQR Therapeutics NV
ProQR Therapeutics NV Posted 153.7% Returns in the Last Month
ProQR Therapeutics NV (PRQR) stock has risen 153.7% in the past month, from $7.35 on August 10 to $18.65 on September 10.
How Vertex Pharmaceuticals’ Drugs Performed in 1Q18
In 1Q18, Vertex Pharmaceuticals’ (VRTX) Orkambi revenue rose ~20% YoY (year-over-year) to $354 million from $295 million.
How Did Kalydeco Perform in 4Q17 and 2017?
In 4Q17, Vertex Pharmaceuticals’ (VRTX) Kalydeco generated revenues of $256 million, a ~45% increase on a year-over-year (or YoY) basis and 20% growth on a quarter-over-quarter (or QoQ) basis.